DK1429769T3 - Nye formuleringer og anvendelse deraf - Google Patents
Nye formuleringer og anvendelse derafInfo
- Publication number
- DK1429769T3 DK1429769T3 DK02799530T DK02799530T DK1429769T3 DK 1429769 T3 DK1429769 T3 DK 1429769T3 DK 02799530 T DK02799530 T DK 02799530T DK 02799530 T DK02799530 T DK 02799530T DK 1429769 T3 DK1429769 T3 DK 1429769T3
- Authority
- DK
- Denmark
- Prior art keywords
- new formulations
- formulations
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103211A SE0103211D0 (sv) | 2001-09-27 | 2001-09-27 | New formulations and use thereof |
PCT/SE2002/001611 WO2003026655A1 (fr) | 2001-09-27 | 2002-09-10 | Nouvelles formulations et utilisation de ces dernieres |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1429769T3 true DK1429769T3 (da) | 2009-05-11 |
Family
ID=20285457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02799530T DK1429769T3 (da) | 2001-09-27 | 2002-09-10 | Nye formuleringer og anvendelse deraf |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1429769B1 (fr) |
JP (2) | JP2005504094A (fr) |
KR (1) | KR20040047866A (fr) |
CN (1) | CN100500147C (fr) |
AR (1) | AR036640A1 (fr) |
AT (1) | ATE420642T1 (fr) |
AU (1) | AU2002334522B2 (fr) |
BR (1) | BR0212857A (fr) |
CA (1) | CA2461517C (fr) |
DE (1) | DE60230883D1 (fr) |
DK (1) | DK1429769T3 (fr) |
ES (1) | ES2322847T3 (fr) |
HK (1) | HK1068555A1 (fr) |
IL (1) | IL160853A0 (fr) |
MX (1) | MXPA04002854A (fr) |
NZ (1) | NZ532527A (fr) |
RU (1) | RU2286153C2 (fr) |
SE (1) | SE0103211D0 (fr) |
WO (1) | WO2003026655A1 (fr) |
ZA (1) | ZA200402363B (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103211D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
SE0103210D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
SE0300831D0 (sv) * | 2003-03-26 | 2003-03-26 | Pharmacia Ab | New formulations and use therof |
BRPI0415741B1 (pt) | 2003-11-07 | 2013-07-23 | composições de tabaco e métodos de fabricação de uma composição de tabaco | |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
AU2005284908B2 (en) | 2004-09-13 | 2011-12-08 | Morningside Venture Investments Limited | Biosynchronous transdermal drug delivery |
GB2468424B (en) * | 2007-04-02 | 2011-11-09 | Parkinson S Inst | Methods and compositions for reduction of side effects of therapeutic treatments |
AU2008232453B8 (en) * | 2007-04-02 | 2011-07-21 | Parkinson's Institute | Methods and compositions for reduction of side effects of therapeutic treatments |
AU2008262870B2 (en) | 2007-06-13 | 2013-07-11 | Otsuka Pharmaceutical Co., Ltd. | Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food |
WO2009070978A1 (fr) * | 2007-11-22 | 2009-06-11 | Yu He | Libération rapide dans la cavité buccale des produits de santé et procédé de préparation associé |
CN101439053A (zh) * | 2007-11-22 | 2009-05-27 | 何煜 | 一种中药口腔速释制剂及其制造方法 |
US9204667B2 (en) * | 2010-12-01 | 2015-12-08 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
WO2013006643A1 (fr) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson |
CN104338133A (zh) * | 2013-07-24 | 2015-02-11 | 陆媛 | 防治口鼻咽喉上呼吸道感染的嚼服药物组合物及其应用 |
WO2015013679A1 (fr) * | 2013-07-26 | 2015-01-29 | Gregory Aharonian | Utilisations de feuille de coca ou de racine de valériane pour réduire l'amertume dans des aliments contenant du cacao non sucré |
JP2015084771A (ja) * | 2013-09-24 | 2015-05-07 | アサヒ飲料株式会社 | 容器詰め果汁含有飲料、容器詰め果汁含有飲料の製造方法及び異風味抑制剤 |
AU2016211330A1 (en) | 2015-01-28 | 2017-08-03 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
JP2018511127A (ja) | 2015-03-12 | 2018-04-19 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 渇望入力及び支援システム |
JP2020503950A (ja) | 2017-01-06 | 2020-02-06 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 経皮薬剤送達の装置及び方法 |
AU2019256805B2 (en) * | 2018-04-16 | 2022-03-03 | Poviva Corp. | Compositions infused with nicotine compounds and methods of use thereof |
EP3801732A4 (fr) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | Procédés et systèmes d'administration de médicament |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8317576D0 (en) * | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
GB8615676D0 (en) * | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
CA1273878A (fr) * | 1987-01-15 | 1990-09-11 | Richard Philip Moody | Preparation de nicotine pour administration transdermique |
DK615689A (da) * | 1989-11-07 | 1991-05-08 | Anders Dam | Rygesupplement eller rygeerstatningsprodukt |
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
FR2717387B1 (fr) * | 1994-03-17 | 1996-10-18 | Hi Pharmtech | Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline. |
SE9803986D0 (sv) * | 1998-11-23 | 1998-11-23 | Pharmacia & Upjohn Ab | New compositions |
SE0103211D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
-
2001
- 2001-09-27 SE SE0103211A patent/SE0103211D0/xx unknown
-
2002
- 2002-09-10 DK DK02799530T patent/DK1429769T3/da active
- 2002-09-10 BR BR0212857-8A patent/BR0212857A/pt active Search and Examination
- 2002-09-10 WO PCT/SE2002/001611 patent/WO2003026655A1/fr active IP Right Grant
- 2002-09-10 CN CNB028191609A patent/CN100500147C/zh not_active Expired - Fee Related
- 2002-09-10 AU AU2002334522A patent/AU2002334522B2/en not_active Ceased
- 2002-09-10 MX MXPA04002854A patent/MXPA04002854A/es active IP Right Grant
- 2002-09-10 JP JP2003530291A patent/JP2005504094A/ja active Pending
- 2002-09-10 KR KR10-2004-7004471A patent/KR20040047866A/ko not_active Application Discontinuation
- 2002-09-10 RU RU2004109153/15A patent/RU2286153C2/ru not_active IP Right Cessation
- 2002-09-10 AT AT02799530T patent/ATE420642T1/de not_active IP Right Cessation
- 2002-09-10 NZ NZ532527A patent/NZ532527A/en not_active IP Right Cessation
- 2002-09-10 EP EP02799530A patent/EP1429769B1/fr not_active Expired - Lifetime
- 2002-09-10 IL IL16085302A patent/IL160853A0/xx unknown
- 2002-09-10 CA CA002461517A patent/CA2461517C/fr not_active Expired - Fee Related
- 2002-09-10 ES ES02799530T patent/ES2322847T3/es not_active Expired - Lifetime
- 2002-09-10 DE DE60230883T patent/DE60230883D1/de not_active Expired - Lifetime
- 2002-09-26 AR ARP020103630A patent/AR036640A1/es unknown
-
2004
- 2004-03-25 ZA ZA2004/02363A patent/ZA200402363B/en unknown
-
2005
- 2005-02-08 HK HK05101072.4A patent/HK1068555A1/xx not_active IP Right Cessation
-
2009
- 2009-10-15 JP JP2009238604A patent/JP2010006845A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2010006845A (ja) | 2010-01-14 |
CN100500147C (zh) | 2009-06-17 |
AR036640A1 (es) | 2004-09-22 |
JP2005504094A (ja) | 2005-02-10 |
NZ532527A (en) | 2005-09-30 |
CN1561214A (zh) | 2005-01-05 |
ES2322847T3 (es) | 2009-06-30 |
RU2004109153A (ru) | 2005-04-20 |
MXPA04002854A (es) | 2005-06-06 |
KR20040047866A (ko) | 2004-06-05 |
HK1068555A1 (en) | 2005-04-29 |
SE0103211D0 (sv) | 2001-09-27 |
WO2003026655A1 (fr) | 2003-04-03 |
CA2461517A1 (fr) | 2003-04-03 |
EP1429769B1 (fr) | 2009-01-14 |
ZA200402363B (en) | 2005-03-30 |
BR0212857A (pt) | 2004-10-13 |
RU2286153C2 (ru) | 2006-10-27 |
ATE420642T1 (de) | 2009-01-15 |
EP1429769A1 (fr) | 2004-06-23 |
AU2002334522B2 (en) | 2007-05-24 |
DE60230883D1 (de) | 2009-03-05 |
CA2461517C (fr) | 2008-09-02 |
IL160853A0 (en) | 2004-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
DK1429769T3 (da) | Nye formuleringer og anvendelse deraf | |
IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
DK1370128T3 (da) | Kombineret ballepresse og ballevikler | |
NO20022289L (no) | Ny anvendelse og nye N-azabisykloamidderivater | |
DK1455785T3 (da) | Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse | |
IS7040A (is) | 5-HT viðtakabindlar og notkun þeirra | |
NO20033456D0 (no) | Modifiserte og stabiliserte GDF-propeptider og anvendelse derav | |
DK1122244T3 (da) | Uracilforbindelser og anvendelse deraf | |
NO20042229L (no) | Type 4-fosfodiestemseinhibitorer og anvendelse derav | |
DK1268425T3 (da) | Carbamatcaspaseinhibitorer og anvendelse deraf | |
NO20031744D0 (no) | Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike | |
IS8074A (is) | Setin 1,4- Díazepín og notkun theirra | |
NO20041272L (no) | Tetracycline derivatives and methods of use thereof | |
NO20034159D0 (no) | Östrogen-gestagen-kombinasjonspreparat og anvendelse derav | |
NO20033854L (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
DK1417189T3 (da) | Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf | |
IS2482B (is) | Arómatísk súlfón og læknisfræðileg notkun þeirra | |
NO20035332D0 (no) | Nye heterocykliske derivater og medisinsk anvendelse derav | |
NO20042693L (no) | Kateterpreparat og anvendelser derav | |
NO20030156D0 (no) | Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav | |
NO20030822L (no) | Nye forbindelser og fremgangsmåter | |
NO20044106L (no) | Omkonstruerte baculoviruser og anvendelse derav | |
IS7961A (is) | Díarýlmetýlídenpíperidínafleiður, lyfjablöndur þeirra og notkun þeirra | |
DK1429770T3 (da) | Nye formuleringer og anvendelse deraf |